mosunetuzumab
roche
['mosunetuzumab', 'lymphoma', 'follicular']
 showing orr of 100% and minimal crs with mosunetuzumab #bispecific in front-line follicular #lymphoma #17icml 
Clinical Director, Lymphoma Program, Fred Hutchinson Cancer Center, University of Washington